![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1367.jpg)
Trials of radiotherapy after mastectomy and axillary dissection
1314 pN1-3 women
Locoregional recurrence
first
Any first recurrence Breast cancer mortality
Years since randomisation Years since randomisation
Years since randomisation
11.5%
7.9
%
RT: Significant benefit
EBCTCG, Lancet 2014